Total testosterone quantitative measurement in serum by LC-MS/MS

Clinica Chimica Acta

Volumn 436, Issue , 2014, Pages 263-267

  Wang, Yuesong ^a   Gay, Gabrielle D ^a   Botelho, Julianne Cook ^a   Caudill, Samuel P ^a   Vesper, Hubert W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Hormone; LC MS MS; Steroids; Testosterone

Indexed keywords

ACETIC ACID ETHYL ESTER; BUFFER; HEXANE; PHOSPHOLIPID; TESTOSTERONE;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CHILD; CONCENTRATION (PARAMETERS); DILUTION; FEMALE; HORMONE DETERMINATION; HUMAN; HUMAN CELL; LIMIT OF DETECTION; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MEASUREMENT ACCURACY; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN ISOLATION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REFERENCE VALUE; TANDEM MASS SPECTROMETRY; TESTOSTERONE BLOOD LEVEL; TESTOSTERONE RELEASE; ANALYTIC SAMPLE PREPARATION METHODS; BLOOD; BLOOD CHEMICAL ANALYSIS; CHROMATOGRAPHY, LIQUID; HUMANS; METHODS;

ADOLESCENT; ANALYTIC SAMPLE PREPARATION METHODS; BLOOD CHEMICAL ANALYSIS; CHILD; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; TANDEM MASS SPECTROMETRY; TESTOSTERONE;

EID: 84903728829     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.06.009     Document Type: Article

References (54)

1. Dobs A.S. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Steroids 2008, 73(13):1305-1310.
2. Goodman N.F., Bledsoe M.B., Cobin R.H., et al. American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Endocr Pract 2001, 7(2):120-134.
3. Robinson S., Rodin D.A., Deacon A., Wheeler M.J., Clayton R.N. Which hormone tests for the diagnosis of polycystic-ovary-syndrome?. Br J Obstet Gynaecol 1992, 99(3):232-238.
4. Araujo A.B., Esche G.R., Kupelian V., et al. Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 2007, 92(11):4241-4247.
5. Kazi M., Geraci S.A., Koch C.A. Considerations for the diagnosis and treatment of testosterone deficiency in elderly men. Am J Med 2007, 120(10):835-840.
6. Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE, American Association of Clinical E American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause: executive summary of recommendations. Endocr Pract 2011, 17(6):949-954.
7. Petak S.M., Nankin H.R., Spark R.F., Swerdloff R.S., Rodriguez-Rigau L.J., American Association of Clinical E American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Endocr Pract 2002, 8(6):440-456.
8. Albrecht L., Styne D. Laboratory testing of gonadal steroids in children. Pediatr Endocrinol Rev 2007, 5(Suppl. 1):599-607.
9. Speiser P.W. Interpretation of pediatric endocrine laboratory tests: pitfalls in steroid hormone measurements and genotyping. Pediatr Endocrinol Rev 2007, 5(Suppl. 1):578-583.
10. Bhasin S., Zhang A., Coviello A., et al. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders. Steroids 2008, 73(13):1311-1317.
11. Dorgan J.F., Longcope C., Franz C., et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002, 94(8):606-616.
12. Sofikerim M., Eskicorapci S., Oruc O., Ozen H. Hormonal predictors of prostate cancer. Urol Int 2007, 79(1):13-18.
13. Albers P., Albrecht W., Algaba F., et al. Guidelines on testicular cancer. Eur Urol 2005, 48(6):885-894.
14. Albers P., Albrecht W., Algaba F., et al. EAU guidelines on testicular cancer: 2011 update. Eur Urol 2011, 60(2):304-319.
15. Wang C., Jackson G., Jones T.H., et al. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care 2011, 34(7):1669-1675.
16. Selvin E., Feinleib M., Zhang L., et al. Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2007, 30(2):234-238.
17. Fink H.A., Ewing S.K., Ensrud K.E., et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 2006, 91(10):3908-3915.
18. Rosano G.M., Cornoldi A., Fini M. Effects of androgens on the cardiovascular system. J Endocrinol Invest 2005, 28(3 Suppl.):32-38.
19. Laughlin G.A., Barrett-Connor E., Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008, 93(1):68-75.
20. Shores M.M., Matsumoto A.M., Sloan K.L., Kivlahan D.R. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006, 166(15):1660-1665.
21. Herold D.A., Fitzgerald R.L. Immunoassays for testosterone in women: better than a guess?. Clin Chem 2003, 49(8):1250-1251.
22. Demers L.M. Testosterone and estradiol assays: current and future trends. Steroids 2008, 73(13):1333-1338.
23. Hsing A.W., Stanczyk F.Z., Belanger A., et al. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry. Cancer Epidemiol Biomarkers Prev 2007, 16(5):1004-1008.
24. Moal V., Mathieu E., Reynier P., Malthiery Y., Gallois Y. Low serum testosterone assayed by liquid chromatography-tandem mass spectrometry. Comparison with five immunoassay techniques. Clin Chim Acta 2007, 386(1-2):12-19.
25. Vesper H.W., Bhasin S., Wang C., et al. Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods. Steroids 2009, 74(6):498-503.
26. Stanczyk F.Z., Clarke N.J. Advantages and challenges of mass spectrometry assays for steroid hormones. J Steroid Biochem Mol Biol 2010, 121(3-5):491-495.
27. Caudill S.P., Schleicher R.L., Pirkle J.L. Multi-rule quality control for the age-related eye disease study. Stat Med 2008, 27(20):4094-4106.
28. Taylor J.K. Quality assurance of chemical measurements 1987, CRC-Press.
29. CDC [Page last updated: Thursday April 25 2013]. http://www.cdc.gov/labstandards/hs.html.
30. Botelho J.C., Shacklady C., Cooper H.C., et al. Isotope-dilution liquid chromatography-tandem mass spectrometry candidate reference method for total testosterone in human serum. Clin Chem 2013, 59(2):372-380.
31. Tai S.S., Xu B., Welch M.J., Phinney K.W. Development and evaluation of a candidate reference measurement procedure for the determination of testosterone in human serum using isotope dilution liquid chromatography/tandem mass spectrometry. Anal Bioanal Chem 2007, 388(5-6):1087-1094.
32. Thienpont L.M., Debrabandere V.I., Stockl D., Deleenheer A.P. Use of cyclodextrins for prepurification of progesterone and testosterone from human serum prior to determination with isotope-dilution gas-chromatography mass-spectrometry. Anal Chem 1994, 66(22):4116-4119.
33. Vesper H.W., Botelho J.C. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol 2010, 121(3-5):513-519.
34. NCCLS Method comparison and bias estimation using patient samples; approved guideline. NCCLS document EP9-A2 2002, Second Edition.
35. Yun Y.M., Botelho J.C., Chandler D.W., et al. Performance criteria for testosterone measurements based on biological variation in adult males: recommendations from the partnership for the accurate testing of hormones. Clin Chem 2012, 58(12):1703-1710.
36. NCCLS Evaluation of precision performance of quantitative measurement methods; approved guideline. NCCLS document EP5-A2 2004, Second Edition.
37. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75(13):3019-3030.
38. Li L.Y., Campbell D.A., Bennett P.K., Henion J. Acceptance criteria for ultratrace HPLC-tandem mass spectrometry: quantitative and qualitative determination of sulfonylurea herbicides in soil. Anal Chem 1996, 68(19):3397-3404.
39. Rodriguez M., Orescan D.B. Confirmation and quantitation of selected sulfonylurea, imidazolinone, and sulfonamide herbicides in surface water using electrospray LC/MS. Anal Chem 1998, 70(13):2710-2717.
40. Rosner W., Auchus R.J., Azziz R., Sluss P.M., Raff H. Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. J Clin Endocrinol Metab 2007, 92(2):405-413.
41. Rosner W., Vesper H., Org E.S.E. Toward excellence in testosterone testing: a consensus statement. J Clin Endocrinol Metab 2010, 95(10):4542-4548.
42. Thienpont L.M., Van Uytfanghe K., Blincko S., et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 2008, 54(8):1290-1297.
43. Neville D., Houghton R., Garrett S. Efficacy of plasma phospholipid removal during sample preparation and subsequent retention under typical UHPLC conditions. Bioanalysis 2012, 4(7):795-807.
44. Little J.L., Wempe M.F., Buchanan C.M. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma. J Chromatogr B Anal Technol Biomed Life Sci 2006, 833(2):219-230.
45. Savolainen K., Kiimamaa R., Halonen T. High-throughput analysis of testosterone in serum samples by on-line solid phase extraction liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2011, 49(11):1845-1848.
46. Shi R.Z., van Rossum H.H., Bowen R.A. Serum testosterone quantitation by liquid chromatography-tandem mass spectrometry: interference from blood collection tubes. Clin Biochem 2012, 45(18):1706-1709.
47. Star-Weinstock M., Williamson B.L., Dey S., Pillai S., Purkayastha S. LC-ESI-MS/MS analysis of testosterone at sub-picogram levels using a novel derivatization reagent. Anal Chem 2012, 84(21):9310-9317.
48. Bui H.N., Struys E.A., Martens F., et al. Serum testosterone levels measured by isotope dilution-liquid chromatography-tandem mass spectrometry in postmenopausal women versus those in women who underwent bilateral oophorectomy. Ann Clin Biochem 2010, 47:248-252.
49. Keski-Rahkonen P., Huhtinen K., Poutanen M., Auriola S. Fast and sensitive liquid chromatography-mass spectrometry assay for seven androgenic and progestagenic steroids in human serum. J Steroid Biochem Mol Biol 2011, 127(3-5):396-404.
50. Cawood M.L., Field H.P., Ford C.G., et al. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin Chem 2005, 51(8):1472-1479.
51. Harwood D.T., Handelsman D.J. Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization. Clin Chim Acta 2009, 409(1-2):78-84.
52. Shiraishi S., Lee P.W., Leung A., Goh V.H., Swerdloff R.S., Wang C. Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clin Chem 2008, 54(11):1855-1863.
53. Wang C., Shiraishi S., Leung A., et al. Validation of a testosterone and dihydrotestosterone liquid chromatography tandem mass spectrometry assay: interference and comparison with established methods. Steroids 2008, 73(13):1345-1352.
54. French D. Development and validation of a serum total testosterone liquid chromatography-tandem mass spectrometry (LC-MS/MS) assay calibrated to NIST SRM 971. Clin Chim Acta 2013, 415:109-117.